Filtros : "Indexado no SCOPUS" "Hirata, Rosario Dominguez Crespo" Removidos: "GRU999QFL" "Indexado no Abstracts Journals" "Epigenomics" Limpar

Filtros



Refine with date range


  • Source: Pharmacogenomics. Unidade: FCF

    Subjects: FARMACOGENÉTICA, EXPRESSÃO GÊNICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      WILLRICH, Maria Alice Vieira e HIRATA, Mario Hiroyuki e HIRATA, Rosario Dominguez Crespo. Statin regulation of CYP3A4 and CYP3A5 expression. Pharmacogenomics, v. 10, n. 6, p. 1017-1024, 2009Tradução . . Disponível em: https://doi.org/10.2217/pgs.09.42. Acesso em: 04 nov. 2024.
    • APA

      Willrich, M. A. V., Hirata, M. H., & Hirata, R. D. C. (2009). Statin regulation of CYP3A4 and CYP3A5 expression. Pharmacogenomics, 10( 6), 1017-1024. doi:10.2217/pgs.09.42
    • NLM

      Willrich MAV, Hirata MH, Hirata RDC. Statin regulation of CYP3A4 and CYP3A5 expression [Internet]. Pharmacogenomics. 2009 ; 10( 6): 1017-1024.[citado 2024 nov. 04 ] Available from: https://doi.org/10.2217/pgs.09.42
    • Vancouver

      Willrich MAV, Hirata MH, Hirata RDC. Statin regulation of CYP3A4 and CYP3A5 expression [Internet]. Pharmacogenomics. 2009 ; 10( 6): 1017-1024.[citado 2024 nov. 04 ] Available from: https://doi.org/10.2217/pgs.09.42
  • Source: Pharmacogenomics. Unidade: FCF

    Subjects: LIPOPROTEÍNAS LDL, HIPERCOLESTEROLEMIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RODRIGUES, Alice Cristina e HIRATA, Mario Hiroyuki e HIRATA, Rosario Dominguez Crespo. Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs. Pharmacogenomics, v. 10, n. 6, p. 1007-1016, 2009Tradução . . Disponível em: https://doi.org/10.2217/pgs.09.18. Acesso em: 04 nov. 2024.
    • APA

      Rodrigues, A. C., Hirata, M. H., & Hirata, R. D. C. (2009). Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs. Pharmacogenomics, 10( 6), 1007-1016. doi:10.2217/pgs.09.18
    • NLM

      Rodrigues AC, Hirata MH, Hirata RDC. Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs [Internet]. Pharmacogenomics. 2009 ; 10( 6): 1007-1016.[citado 2024 nov. 04 ] Available from: https://doi.org/10.2217/pgs.09.18
    • Vancouver

      Rodrigues AC, Hirata MH, Hirata RDC. Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs [Internet]. Pharmacogenomics. 2009 ; 10( 6): 1007-1016.[citado 2024 nov. 04 ] Available from: https://doi.org/10.2217/pgs.09.18
  • Source: Genetic Testing and Molecular Biomarkers. Unidade: FCF

    Subjects: POLIMORFISMO, REAÇÃO EM CADEIA POR POLIMERASE

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LIMA NETO, Lidio Gonçalves et al. Detection of the TLR4 1196C>T polymorphism by mismatched-polymerase chain reaction using plasmid DNA as internal control in restriction fragment length polymorphism assays. Genetic Testing and Molecular Biomarkers, v. 13, n. 3, p. 343-347, 2009Tradução . . Disponível em: http://www.liebertonline.com/doi/pdfplus/10.1089/gtmb.2008.0147. Acesso em: 04 nov. 2024.
    • APA

      Lima Neto, L. G., Hirata, R. D. C., Luchessi, A. D., Silbiger, V. N., Pastorelli, C. P., Sampaio, M. F., et al. (2009). Detection of the TLR4 1196C>T polymorphism by mismatched-polymerase chain reaction using plasmid DNA as internal control in restriction fragment length polymorphism assays. Genetic Testing and Molecular Biomarkers, 13( 3), 343-347. Recuperado de http://www.liebertonline.com/doi/pdfplus/10.1089/gtmb.2008.0147
    • NLM

      Lima Neto LG, Hirata RDC, Luchessi AD, Silbiger VN, Pastorelli CP, Sampaio MF, Armaganijan D, Rezende AA de, Doi S de Q, Hirata MH. Detection of the TLR4 1196C>T polymorphism by mismatched-polymerase chain reaction using plasmid DNA as internal control in restriction fragment length polymorphism assays [Internet]. Genetic Testing and Molecular Biomarkers. 2009 ; 13( 3): 343-347.[citado 2024 nov. 04 ] Available from: http://www.liebertonline.com/doi/pdfplus/10.1089/gtmb.2008.0147
    • Vancouver

      Lima Neto LG, Hirata RDC, Luchessi AD, Silbiger VN, Pastorelli CP, Sampaio MF, Armaganijan D, Rezende AA de, Doi S de Q, Hirata MH. Detection of the TLR4 1196C>T polymorphism by mismatched-polymerase chain reaction using plasmid DNA as internal control in restriction fragment length polymorphism assays [Internet]. Genetic Testing and Molecular Biomarkers. 2009 ; 13( 3): 343-347.[citado 2024 nov. 04 ] Available from: http://www.liebertonline.com/doi/pdfplus/10.1089/gtmb.2008.0147
  • Source: Pharmacogenomics. Unidade: FCF

    Subjects: EXPRESSÃO GÊNICA, LIPOPROTEÍNAS LDL

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GENVIGIR, Fabiana Dalla Vecchia e HIRATA, Mario Hiroyuki e HIRATA, Rosario Dominguez Crespo. ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells. Pharmacogenomics, v. 10, n. 6, p. 997-1005, 2009Tradução . . Disponível em: https://doi.org/10.2217/pgs.09.30. Acesso em: 04 nov. 2024.
    • APA

      Genvigir, F. D. V., Hirata, M. H., & Hirata, R. D. C. (2009). ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells. Pharmacogenomics, 10( 6), 997-1005. doi:10.2217/pgs.09.30
    • NLM

      Genvigir FDV, Hirata MH, Hirata RDC. ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells [Internet]. Pharmacogenomics. 2009 ; 10( 6): 997-1005.[citado 2024 nov. 04 ] Available from: https://doi.org/10.2217/pgs.09.30
    • Vancouver

      Genvigir FDV, Hirata MH, Hirata RDC. ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells [Internet]. Pharmacogenomics. 2009 ; 10( 6): 997-1005.[citado 2024 nov. 04 ] Available from: https://doi.org/10.2217/pgs.09.30
  • Source: European Journal of Pharmaceutical Sciences. Unidades: ICB, FCF

    Subjects: EXPRESSÃO GÊNICA, FARMACOGENÉTICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RODRIGUES, Alice Cristina et al. Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells. European Journal of Pharmaceutical Sciences, v. 37, n. 3-4, p. 486-491, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2009.04.006. Acesso em: 04 nov. 2024.
    • APA

      Rodrigues, A. C., Curi, R., Hirata, M. H., & Hirata, R. D. C. (2009). Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells. European Journal of Pharmaceutical Sciences, 37( 3-4), 486-491. doi:10.1016/j.ejps.2009.04.006
    • NLM

      Rodrigues AC, Curi R, Hirata MH, Hirata RDC. Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells [Internet]. European Journal of Pharmaceutical Sciences. 2009 ; 37( 3-4): 486-491.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.ejps.2009.04.006
    • Vancouver

      Rodrigues AC, Curi R, Hirata MH, Hirata RDC. Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells [Internet]. European Journal of Pharmaceutical Sciences. 2009 ; 37( 3-4): 486-491.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.ejps.2009.04.006

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024